These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7333823)

  • 1. Plasmapheresis in the treatment of four cases of Guillain-Barré syndrome (acute form).
    Zerbi D; Celano I; Forlani G; Garelli S; Mosconi L; Valbonesi M
    Ital J Neurol Sci; 1981 Dec; 2(4):331-6. PubMed ID: 7333823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune complex levels and plasmapheresis in Guillain-Barré syndrome.
    Tharakan JK; Mathai J; Mathai A; Sulochana PV
    Acta Neurol (Napoli); 1993 Apr; 15(2):138-41. PubMed ID: 8328324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular respiratory failure in Guillain-Barre Syndrome: evaluation of clinical and electrodiagnostic predictors.
    Sundar U; Abraham E; Gharat A; Yeolekar ME; Trivedi T; Dwivedi N
    J Assoc Physicians India; 2005 Sep; 53():764-8. PubMed ID: 16334619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of the efficacy of plasma exchange, immunoadsorption plasmapheresis and corticosteroid administration in the treatment of Guillain-Barré syndrome].
    Yamazaki M; Koh CS; Hanyu N; Sakai T; Inoue A; Yanagisawa N
    Arerugi; 1995 Apr; 44(4):498-502. PubMed ID: 7598643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group.
    Neurology; 1985 Aug; 35(8):1096-104. PubMed ID: 4022342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic studies in the Guillain-Barré syndrome: effects of plasma exchange and antibody rebound.
    Rudnicki S; Vriesendorp F; Koski CL; Mayer RF
    Muscle Nerve; 1992 Jan; 15(1):57-62. PubMed ID: 1732763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
    Tagawa Y; Yuki N
    Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?].
    Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA
    Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and neurophysiologic study of Guillain Barré syndrome: results of therapy with plasmapheresis].
    Fasanaro AM; Pizza V; Florio C; Tancredi G; Fabbri P; Aiello L; Viscidi E; Rossi V; Vacca C
    Riv Neurol; 1991; 61(1):39-45. PubMed ID: 1857922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasmapheresis therapy in Guillain-Barré polyneuroradiculitis].
    Zwahlen H; Quadri F; Mombelli G; Tatti V; Marone C
    Schweiz Med Wochenschr; 1988 Dec; 118(49):1854-8. PubMed ID: 3217776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasmapheresis in 2 children with Guillain-Barré syndrome].
    Rotteveel JJ; Mullaart RA; Weemaes CM; van Empelen R
    Tijdschr Kindergeneeskd; 1983 Apr; 51(2):57-62. PubMed ID: 6879585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior interosseous syndrome in acute Guillain-Barré syndrome.
    Baba M; Matsunaga M; Ozaki I
    Electromyogr Clin Neurophysiol; 1994 Sep; 34(6):367-71. PubMed ID: 8001479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guillain-Barré syndrome: clinical features, immune mechanisms, and therapies].
    Nomura K
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1367-9. PubMed ID: 9128414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasmapheresis and hormone therapy in severe forms of Guillain-Barré syndrome].
    Levchenko NI; Piradov MA; Pirogov VN
    Klin Med (Mosk); 1989 Dec; 67(12):88-91. PubMed ID: 2560799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.
    Okamiya S; Ogino M; Ogino Y; Irie S; Kanazawa N; Saito T; Sakai F
    Ther Apher Dial; 2004 Jun; 8(3):248-53. PubMed ID: 15154879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical course and treatment of acute inflammatory demyelinating polyradiculoneuropathy (Landry-Guillain-Barré syndrome)].
    Mozolevskiĭ IuV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(2):6-9. PubMed ID: 1326178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of plasmapheresis in the treatment of Guillain-Barre acute polyradiculoneuritis].
    Lovaste MG; Thiam A; Andreotti C; Ferrari G
    Dakar Med; 1990; 35(1):18-24. PubMed ID: 2131187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma exchange as a therapy for Guillain-Barré syndrome with immune complexes.
    Valbonesi M; Garelli S; Mosconi L; Zerbi D; Celano I
    Vox Sang; 1981; 41(2):74-8. PubMed ID: 7331282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlation with anti-peripheral-nerve myelin antibodies in Guillain-Barré syndrome.
    Koski CL; Gratz E; Sutherland J; Mayer RF
    Ann Neurol; 1986 Jun; 19(6):573-7. PubMed ID: 3729311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasmapheresis and high-dose immunoglobulins in the treatment of acute demyelinating polyneuropathy].
    Marino A; Logi G; Roncucci P; Sodini ML; Fornaini F
    Minerva Anestesiol; 1993 Jun; 59(6):307-11. PubMed ID: 8414090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.